Tianshui Zhongxing Bio-technology Co Ltd
SZSE:002772

Watchlist Manager
Tianshui Zhongxing Bio-technology Co Ltd Logo
Tianshui Zhongxing Bio-technology Co Ltd
SZSE:002772
Watchlist
Price: 19 CNY 2.76%
Market Cap: ¥7.1B

Income Statement

Earnings Waterfall
Tianshui Zhongxing Bio-technology Co Ltd

Income Statement
Tianshui Zhongxing Bio-technology Co Ltd

Rotate your device to view
Income Statement
Currency: CNY
Jun-2015 Sep-2015 Dec-2015 Mar-2016 Jun-2016 Sep-2016 Dec-2016 Mar-2017 Jun-2017 Sep-2017 Dec-2017 Mar-2018 Jun-2018 Sep-2018 Dec-2018 Mar-2019 Jun-2019 Sep-2019 Dec-2019 Mar-2020 Jun-2020 Sep-2020 Dec-2020 Mar-2021 Jun-2021 Sep-2021 Dec-2021 Mar-2022 Jun-2022 Sep-2022 Dec-2022 Mar-2023 Jun-2023 Sep-2023 Dec-2023 Mar-2024 Jun-2024 Sep-2024 Dec-2024 Mar-2025 Jun-2025 Sep-2025 Dec-2025
Revenue
Interest Expense
0
0
15
0
0
0
5
0
0
1
3
0
0
5
22
32
49
61
75
78
0
68
86
64
79
78
81
84
95
92
90
79
77
78
84
87
84
82
77
72
0
0
57
Revenue
426
N/A
444
+4%
480
+8%
533
+11%
539
+1%
575
+7%
585
+2%
571
-2%
640
+12%
683
+7%
740
+8%
839
+13%
835
0%
910
+9%
926
+2%
967
+4%
1 021
+6%
1 010
-1%
1 156
+14%
1 215
+5%
1 280
+5%
1 422
+11%
1 483
+4%
1 512
+2%
1 554
+3%
1 508
-3%
1 556
+3%
1 649
+6%
1 711
+4%
1 942
+14%
1 970
+1%
2 105
+7%
2 130
+1%
1 978
-7%
1 931
-2%
1 795
-7%
1 827
+2%
1 895
+4%
1 935
+2%
1 921
-1%
1 928
+0%
1 994
+3%
2 098
+5%
Gross Profit
Cost of Revenue
(263)
(267)
(283)
(299)
(312)
(335)
(356)
(384)
(424)
(469)
(507)
(556)
(602)
(636)
(669)
(723)
(744)
(809)
(880)
(923)
(978)
(1 029)
(1 075)
(1 142)
(1 200)
(1 230)
(1 268)
(1 320)
(1 377)
(1 435)
(1 473)
(1 468)
(1 454)
(1 473)
(1 494)
(1 526)
(1 547)
(1 539)
(1 545)
(1 510)
(1 515)
(1 503)
(1 498)
Gross Profit
162
N/A
176
+9%
197
+12%
234
+19%
227
-3%
241
+6%
229
-5%
187
-18%
216
+15%
214
-1%
233
+9%
283
+21%
233
-18%
274
+18%
258
-6%
244
-5%
277
+13%
201
-27%
276
+37%
292
+6%
302
+4%
393
+30%
408
+4%
370
-9%
355
-4%
278
-22%
288
+4%
329
+14%
334
+2%
507
+52%
498
-2%
637
+28%
676
+6%
504
-25%
437
-13%
269
-38%
280
+4%
356
+27%
390
+9%
412
+5%
413
+0%
491
+19%
600
+22%
Operating Income
Operating Expenses
(64)
(69)
(85)
(86)
(88)
(92)
(94)
(102)
(111)
(118)
(135)
(138)
(150)
(155)
(169)
(157)
(144)
(142)
(148)
(171)
(177)
(184)
(184)
(186)
(198)
(205)
(187)
(199)
(205)
(220)
(232)
(242)
(238)
(229)
(235)
(240)
(246)
(251)
(244)
(253)
(254)
(249)
(250)
Selling, General & Administrative
(63)
(69)
(79)
(85)
(87)
(91)
(87)
(104)
(116)
(126)
(136)
(153)
(165)
(167)
(168)
(164)
(152)
(153)
(149)
(163)
(170)
(180)
(191)
(206)
(217)
(223)
(199)
(222)
(227)
(229)
(234)
(242)
(237)
(235)
(231)
(239)
(244)
(247)
(235)
(246)
(246)
(244)
(242)
Research & Development
0
0
(2)
0
0
0
(1)
0
0
0
(1)
0
0
(3)
(3)
(4)
(5)
(3)
(3)
(5)
(5)
(6)
(6)
(7)
(7)
(8)
(6)
(8)
(9)
(11)
(9)
(11)
(12)
(12)
(12)
(14)
(14)
(13)
(14)
(14)
(14)
(14)
(16)
Depreciation & Amortization
0
0
(4)
0
0
0
(6)
0
0
0
(7)
0
0
0
(8)
0
0
0
(11)
0
0
0
(13)
0
0
0
(13)
0
0
0
(13)
0
0
0
(14)
0
0
0
(14)
0
0
0
(14)
Other Operating Expenses
(0)
0
(0)
(1)
(1)
(1)
(0)
3
5
7
10
15
16
16
10
11
13
14
16
(4)
(2)
2
25
27
25
26
31
30
31
20
24
11
10
18
22
13
12
9
19
7
6
9
22
Operating Income
99
N/A
108
+9%
112
+4%
148
+32%
140
-6%
148
+6%
135
-9%
86
-36%
104
+22%
96
-8%
98
+3%
145
+48%
83
-43%
119
+45%
89
-25%
87
-2%
133
+52%
59
-56%
129
+118%
121
-6%
125
+4%
210
+67%
224
+7%
184
-18%
156
-15%
73
-53%
101
+38%
129
+29%
129
-1%
287
+123%
265
-7%
396
+49%
438
+11%
276
-37%
202
-27%
29
-86%
34
+18%
105
+209%
146
+39%
158
+8%
159
+1%
242
+52%
350
+45%
Pre-Tax Income
Interest Income Expense
(11)
(12)
(8)
(2)
2
8
19
27
37
44
41
45
38
33
25
5
(4)
(13)
(34)
(37)
(43)
(55)
(33)
(27)
(9)
(35)
(17)
(75)
(74)
(46)
(89)
(46)
(59)
(58)
(43)
(34)
(46)
(36)
(19)
(13)
14
8
(2)
Non-Reccuring Items
0
0
0
0
0
0
(1)
0
0
(1)
0
0
0
(0)
(1)
0
0
0
(25)
0
0
0
(2)
0
0
0
(0)
0
0
0
(10)
(0)
0
0
(0)
(0)
0
(0)
(3)
(7)
(7)
(8)
(13)
Gain/Loss on Disposition of Assets
0
0
0
0
(0)
(0)
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Total Other Income
7
7
11
10
11
14
8
12
9
6
4
(8)
(8)
(8)
(1)
(1)
0
0
(1)
(8)
(7)
(5)
(0)
1
(2)
(20)
(29)
(30)
(33)
(18)
(7)
(6)
(1)
(1)
1
1
2
2
1
1
0
(0)
1
Pre-Tax Income
95
N/A
102
+7%
115
+13%
157
+36%
153
-3%
170
+11%
161
-5%
124
-23%
149
+20%
145
-3%
143
-1%
182
+27%
113
-38%
144
+28%
113
-22%
91
-19%
129
+41%
46
-64%
69
+49%
76
+10%
75
-1%
150
+99%
190
+26%
158
-17%
145
-8%
19
-87%
54
+191%
25
-54%
22
-13%
223
+918%
159
-29%
344
+116%
377
+10%
216
-43%
160
-26%
(5)
N/A
(10)
-97%
71
N/A
127
+78%
140
+11%
166
+19%
243
+46%
336
+38%
Net Income
Tax Provision
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
(0)
0
0
0
0
0
0
0
0
0
0
0
(1)
Income from Continuing Operations
95
102
115
157
153
170
161
124
149
145
143
182
113
144
113
91
129
46
69
76
75
150
190
158
145
19
54
25
22
223
159
344
377
216
160
(5)
(10)
71
127
140
166
243
335
Income to Minority Interest
0
0
(1)
(3)
(2)
(3)
(3)
(1)
(2)
(1)
(1)
(1)
(0)
(1)
(1)
(0)
(2)
(1)
(1)
(0)
(0)
(1)
(1)
(0)
0
1
1
1
1
(0)
(1)
(1)
(2)
(1)
0
1
2
1
1
1
2
1
0
Net Income (Common)
95
N/A
102
+7%
114
+12%
154
+35%
151
-2%
167
+11%
159
-5%
122
-23%
147
+20%
144
-2%
142
-1%
180
+27%
113
-37%
143
+27%
112
-22%
91
-19%
127
+40%
46
-64%
68
+50%
76
+11%
75
-1%
150
+99%
189
+26%
158
-17%
145
-8%
19
-87%
55
+185%
26
-53%
22
-13%
222
+892%
158
-29%
342
+116%
376
+10%
216
-43%
160
-26%
(4)
N/A
(8)
-123%
73
N/A
128
+76%
141
+11%
168
+18%
244
+45%
335
+37%
EPS (Diluted)
0.37
N/A
0.33
-11%
0.4
+21%
0.49
+22%
0.48
-2%
0.52
+8%
0.47
-10%
0.33
-30%
0.41
+24%
0.39
-5%
0.39
N/A
0.49
+26%
0.3
-39%
0.38
+27%
0.32
-16%
0.24
-25%
0.37
+54%
0.12
-68%
0.19
+58%
0.21
+11%
0.21
N/A
0.43
+105%
0.56
+30%
0.47
-16%
0.39
-17%
0.05
-87%
0.14
+180%
0.06
-57%
0.06
N/A
0.58
+867%
0.4
-31%
0.8
+100%
1.03
+29%
0.54
-48%
0.39
-28%
0
N/A
-0.02
N/A
0.19
N/A
0.33
+74%
0.37
+12%
0.44
+19%
0.65
+48%
0.89
+37%
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett